Home › Lymphoma › Illinois › Chicago
Pag-aaral pangklinika para sa Lymphoma sa Chicago, IL
19 pag-aaral para sa Lymphoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Chicago (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Nagre-recruitPhase 1/2
- Call for Information (Investigational Site 0024), Chicago
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Nagre-recruitPhase 2
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Nagre-recruitPhase 3
- Northwestern, Chicago
- University of Chicago, Chicago
Mosaic Trial for Stem Cell Transplant Recipients
Nagre-recruit
- Northwestern University Feinberg School of Medicine, Chicago
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Nagre-recruit
- University of Chicago Comprehensive Cancer Center, Chicago
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Nagre-recruitPhase 1
- The David and Etta Jonas Center for Cellular Therapy, Chicago
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Nagre-recruitPhase 1/2
- Northwestern Memorial Hospital, Chicago
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
Nagre-recruitPhase 3
- Research Site, Chicago
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Nagre-recruitPhase 1
- Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Nagre-recruitPhase 1/2
- Lurie Children's Hospital-Chicago, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
Nagre-recruitPhase 1/2
- University of Chicago, Chicago
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Nagre-recruitPhase 1/2
- University of Chicago Medical Center, Chicago
DALY II USA/ MB-CART2019.1 for DLBCL
Nagre-recruitPhase 2
- Robert H Lurie Cancer Center, Chicago
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Nagre-recruitPhase 1
- Northwestern University, Chicago
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Nagre-recruitObservasyonal na pag-aaral
- Lurie Children's Hospital-Chicago, Chicago
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Nagre-recruitPhase 1/2
- University of Illinois at Chicago Cancer Center, Chicago
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Nagre-recruitPhase 1
- The University of Chicago Medical Center, Chicago
CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL
Nagre-recruitPhase 1/2
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
Avo In R/R And Previously Untreated MCL
Nagre-recruitPhase 1/2
- University of Chicago Medical Center, Chicago
Pag-aaral para sa Lymphoma sa ibang lungsod
- Houston, TX34 pag-aaral
- Boston, MA34 pag-aaral
- New York City, NY33 pag-aaral
- Washington, DC23 pag-aaral
- Baldwin Park, CA22 pag-aaral
- Durham, NC17 pag-aaral
- St. Louis, MO15 pag-aaral
- Cleveland, OH13 pag-aaral
- Seattle, WA13 pag-aaral
- Atlanta, GA13 pag-aaral
- Philadelphia, PA13 pag-aaral
- Edison, NJ12 pag-aaral
Iba pang pag-aaral sa Chicago
- Kanser sa Suso59 pag-aaral
- Non-Small Cell Lung Cancer59 pag-aaral
- Kanser (lahat ng uri)51 pag-aaral
- Kanser sa Prostate45 pag-aaral
- Kanser sa Baga43 pag-aaral
- Metastatic Cancer42 pag-aaral
- Obesity40 pag-aaral
- Kanser sa Ovary36 pag-aaral
- Colorectal Cancer32 pag-aaral
- Stroke31 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg29 pag-aaral
- Overweight29 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.